ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis

Bi, Yiming; Han, Xin; Lai, Yigui; Fu, Yingchang; Li, Kongzheng; Zhang, Wei; Wang, Qiang; Jiang, Xuefeng; Zhou, Yingchun*; Liang, Hongfeng*; Fan, Huijie*南方医科大学
Journal of Ethnopharmacology2021-10-5DOI: 10.1016/j.jep.2021.114278
12被引29阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Atherosclerosis (AS) plays an important role in the pathogenesis of cardiovascular and cerebrovascular diseases. Danggui-Shaoyao-San (DSS) is not only a representative Chinese formula to treat gynecological disorder, but also found its use in AS-related diseases. However, the active ingredients and the anti-AS effects are vague yet. Aim of the study: An integrated strategy combined ultrahigh-performance liquid chromatography quadrupoleOrbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap-HRMS), network pharmacology and experiments was carried out to investigate the potential materials and pharmacological mechanisms of DSS for AS. Materials and methods: First, UHPLC-Q-Orbitrap-HRMS was applied to identify the active compositions of DSS. Then, the putative targets of DSS relevant to AS were predicted from TCMSP and BATMAN, which were further determined through bioinformatic analyses, including protein-protein interactions (PPI), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG). Finally, Western blot, qPCR and ELISA were carried out for target validation in human umbilical vein endothelial cells (HUVECs). Results: A total of 37 active ingredients of DSS, connecting 47 key targets were identified. The functional enrichment showed that DSS may treat AS through regulating a series of signaling pathways which involving inflammatory responses, immune systems and metabolism. The in vitro experiment revealed that DSS ameliorated AS mainly through anti-inflammatory effects, by reducing the levels of vascular cell adhesion molecule-1 (VCAM1), intercellular adhesion molecule-1 (ICAM1), IL-6, TNF-alpha, cyclooxygenase-2 (Cox-2) and IL-1 beta. DSS also inhibited the phosphorylation of I Kappa B-alpha, NF-Kappa B (p65), p38 and JNK in lipopolysaccharide (LPS)-induced HUVEC injury model. Moreover, as the main bioactive compounds of DSS, paeoniflorin (PF), ferulic acid (FA) and pachymic acid (PA) inhibited IL-6 and TNF-alpha secretion as well as I Kappa B-alpha, NF-Kappa B (p65), p38 and JNK activation. All these findings were consistent with the predicted targets and pathways. Conclusion: Collectively, the basic pharmacological effects and relevant mechanisms of DSS in the treatment of AS were revealed. The results suggest that DSS is a potential drug for AS treatment, and PF, FA, PA may be the core compositions contributing to the pharmacological function of this formula.

学科与关键词

关键词
Danggui-shaoyao-sanAtherosclerosisUHPLC-Q-orbitrap-HRMSNetwork pharmacology
相关
加载中…
  • Material basis and integrative pharmacology of danshen decoction in the treatment of cardiovascular diseases
    Liu, Mengnan; Li, Ziyi; Ouyang, Yue; Chen, Mingtai; Guo, Xin; Mazhar, Maryam; Kang, Junli; Zhou, Hua*; Wu, Qibiao*; Yang, Sijin*PHYTOMEDICINE, 2023, 108: 154503.被引 2
  • Tanshinone IIA Alleviates Atherosclerosis Through Inhibition of NF-κB and PPARαE/ABCA1 Signaling Pathways
    He, Dequan; Zhang, Jiawei; Chen, Youquan; Li, Zhiliang*Journal of Biomedical Nanotechnology, 2023, 19(10): 1824-1831.
  • Therapeutic potential of paeoniflorin in atherosclerosis: A cellular action and mechanism-based perspective
    Yu, Wei; Ilyas, Iqra; Hu, Xuerui; Xu, Suowen; Yu, Hui*Frontiers in Immunology, 2022, 13: 1072007.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2021-10-05
卷期
第 278 卷
页码
114278
DOI
10.1016/j.jep.2021.114278
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE

作者

  • B

    Bi, Yiming (第一作者)

    southern med univ

  • H

    Han, Xin

    southern med univ

查看全部 11 位作者收起作者
  • L

    Lai, Yigui

  • F

    Fu, Yingchang

  • L

    Li, Kongzheng

  • Z

    Zhang, Wei

  • W

    Wang, Qiang

  • J

    Jiang, Xuefeng

    southern med univ

  • Z

    Zhou, Yingchun (通讯)

    southern med univ

  • L

    Liang, Hongfeng (通讯)

  • F

    Fan, Huijie (通讯)

    southern med univ · liaoning univ tradit chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417